Preventing vision loss from glaucoma is all about saving a cell’s life.
Retinal ganglion cells in the eye that help turn light into information are the crucial cells threatened in glaucoma.
Treatments to reduce pressure in the eye can help, but at CERA we know that there are better ways to rescue them and prevent vision loss for the 300,000 Australians affected by glaucoma.
These are just waiting to be discovered.
In the autumn edition of Visionary, coinciding with World Glaucoma Week, we introduce you to the researchers who are passionately working to discover new ways to save cells and protect vision.
We welcome to CERA Professor Pete Williams, whose research is focused on finding ways to give cells in the eye more energy to stop them dying.
We introduce you to Asher Kozma, a young man who is a big advocate of CERA’s research and who has been involved in our glaucoma clinical trials.
He lives with pigment dispersion syndrome – a condition that if not managed can develop into of glaucoma.
Dr Flora Hui updates us on the CERA led, world-first clinical trial, which aims to discover if vitamin B3 delivered with current treatments can support cell function in the eye.
Whilst Associate Professor Luis Alarcon‑Martinez explains how blood flow has the potential to treat glaucoma, rather than just manage it. These researchers are working tirelessly to find the missing link to detect and prevent glaucoma.
With your ongoing support, we are closer than ever to our shared goal of a world free from vision loss and blindness.
There is hope for the 300,000 Australians with glaucoma.
With best wishes,
Professor Keith Martin
Managing Director
Centre for Eye Research Australia
